Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1289 studies found for:    "Fibrin Modulating Agents"
Show Display Options
Rank Status Study
1 Recruiting Tranexamic Acid in Reverse Total Shoulder Arthroplasty
Conditions: Shoulder Joint Disease;   Complications; Arthroplasty;   Intraoperative Complications;   Blood Loss, Surgical
Intervention: Drug: Infusion Tranexamic acid or placebo.
2 Recruiting STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial
Conditions: Intracerebral Haemorrhage;   Stroke
Interventions: Drug: Tranexamic Acid;   Drug: Placebo
3 Recruiting Clinical Efficacy of Tranexamic Acid and ε-Aminocaproic Acid in Reducing Blood Loss Following Total Knee Replacement
Condition: Osteoarthritis
Interventions: Drug: Tranexamic Acid (TXA);   Drug: ε-Aminocaproic Acid (EACA)
4 Active, not recruiting The Intravascular Cooling in the Treatment of Stroke 2/3 Trial
Condition: Stroke, Acute
Interventions: Device: hypothermia;   Other: Group1: IV t-PA and normothermia
5 Completed
Has Results
Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Intervention: Drug: Rivaroxaban (Xarelto, BAY59-7939)
6 Unknown  PP13 and Doppler Study to Predict Preeclampsia
Condition: Preeclampsia
Interventions: Drug: Progesterone;   Drug: Low molecular weight Heparin;   Drug: No Drug
7 Completed Effects of Aspirin Treatment on Fibrin Network Formation in Patients With Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Intervention: Drug: Aspirin
8 Completed
Has Results
Tranexamic Acid (TA) vs Combined Oral Contraceptive (COCP) Pilot Study
Condition: Menorrhagia
Interventions: Drug: Oral tranexamic acid;   Drug: Oral Contraceptive Pills
9 Completed Aspirin Use and Postoperative Bleeding From Dental Extractions in a Healthy Population
Condition: Bleeding Complication
Intervention: Drug: Aspirin
10 Completed
Has Results
Quantifying Airway Inflammation With Radiologic Tests
Condition: Lung Inflammation
Interventions: Drug: placebo pill and placebo IV;   Drug: Lovastatin pill and placebo IV;   Drug: placebo pill and recombinant human activated protein C IV;   Biological: Endotoxin
11 Completed Treatment for Blood Clots in the Veins of the Legs
Conditions: Embolism;   Thrombophlebitis
Interventions: Drug: Recombinant Tissue Plasminogen Activator;   Drug: Heparin;   Drug: Warfarin
12 Completed Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer
Condition: Thrombosis, Venous
Intervention: Drug: Nadroparin
13 Recruiting Phase 4 Study of Effect of Aspirin on Flushing in Dimethyl Fumarate (DMF)-Treated Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)
Condition: Relapsing-Remitting Multiple Sclerosis
Interventions: Drug: dimethyl fumarate;   Drug: Acetylsalicylic acid;   Drug: ASA-Placebo
14 Completed Daily Vitamin K in Patients on Warfarin With Unstable INRs
Conditions: Anticoagulants;   Warfarin
Intervention: Drug: Vitamin K
15 Recruiting Tranexamic Acid During Cystectomy Trial (TACT) Pilot Study
Condition: Bladder Cancer
Interventions: Drug: Tranexamic Acid;   Drug: Placebo
16 Recruiting Effect of Vitamin K Supplementation on Markers of Diabetes Risk in Overweight Children
Conditions: Obesity;   Insulin Resistance;   Insulin Sensitivity;   Beta-Cell Dysfunction;   Prediabetes
Interventions: Dietary Supplement: Placebo-Control;   Dietary Supplement: Low-Dose Vitamin K2 (menaquinone-7; 45 mcg/d);   Dietary Supplement: High-Dose Vitamin K2 (menaquinone-7; 90 mcg/d)
17 Completed Unfractioned Heparin for Treatment of Sepsis
Conditions: Sepsis;   Bacterial Infections
Interventions: Drug: Unfractioned heparin;   Drug: saline
18 Completed The D-KAF (Dalteparin in Knee-to-Ankle Fracture) Trial
Conditions: Deep Vein Thrombosis;   Pulmonary Embolism
Intervention: Drug: Low Molecular Weight Heparin (dalteparin)
19 Withdrawn Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection
Condition: Ischemic Stroke
Interventions: Drug: aspirin;   Drug: warfarin
20 Completed Effect of Sulodexide in Early Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: Sulodexide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years